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Resistance to intracellularmicroorganisms such as mycobacteria is dependent on
antigen-specific MHC class II-restrictedhelper Tcells (Th) (1). Th cells are thought
to release macrophage-activating factors that enable macrophages to eliminate the
infectious organism (1). It has recently become clear, however, that exposure to in-
tracellular parasites not only induces a Th cell but also a CTL response. CTL may
be important effector cells in the protective immune response to these parasites
(reviewed in reference 2). For example, Mycobacterium leprae and M. bovis BCG are
potent inducers of antigen-specific HLA-restricted CTL that lyse human macro-
phages (3, 4). These CTL can belong to both the CD8+ and the CD4* subset, and
are readily detectable after primary in vitro exposure of PBMC to antigen (3, 4,
Birhane Kale Ab, R. Kiessling, P Converse, E. Halapi, G. Tadesse, and T H. M.
Ottenhoff, manuscript submitted for publication). We have also shown that the 65-
kD mycobacterial heat shock protein (hsp)l is an important target antigen forpoly-
clonal CD4+ HLA-DR-restricted CTL (3, 5).
CTL lyse target cellsthat express the ligand for the TCR, i.e., a peptidefragment
ofantigen complexed to an MHC molecule (6, 7). Such antigen fragmentsare pro-
duced by the processing machinery ofthe target cell, and can often be replaced by
synthetic peptides (7). Thus, target cells become susceptible to CTL-mediated lysis
upon incubation with exogenous, "preprocessed" peptide antigen in vitro. CTL lyse
target cells through a complex mechanism, that mayinvolve the release ofcytotoxic
granules that contain lytic effector moleculeslike perforin, serine esterases, and var-
ious other mediators, but also granule exocytosis-independent lytic pathways have
been described (reviewed inreferences 8, 9). In either case, however, CTLwere found
to be remarkably resistant against lysis by themselves (8-10), by otherprimary (11)
or cloned (8-10, 12-15) CTL, by purified granules (11, 14-16), and by purified per-
forin itself (17, 18). Most studies addressing this CTL resistance to lysis have been
performed with mouse CD8+ CTL.
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We have now further characterized the CTL response against the mycobacterial
65-kD hsp. We found that the mycobacterial 65-kD hsp triggers CD4* CTL clones
that are specific for different peptide defined epitopes (19, 20). These CTL not only
lyse APCs but also CD4+ or CD8+ CTL clones, including themselves, that carry
the proper peptide/HLA class II complex. CD4+ CTL are therefore not by defini-
tion resistant to CTL- or self-mediated lysis; in addition, CTL-mediated CTL lysis
may represent a novel immunoregulatory pathway in man, since human T cells,
in contrast to murine, express MHC class II .
Materials and Methods
Antigens.
￿
The recombinant 65-kD hsp of M. bovis BCG was a gift of Dr. J . D. A. van
Embden (Bilthoven, The Netherlands). Peptides of the M. leprae 65-kD hsp were made by
solid-phase peptide synthesis and checked by analytical reverse-phase HPLC and amino acid
analysis as described previously (20), and were a kind gift of Dr. D. C. Anderson (Seattle,
WA). The Plasmodiumfalciparum CS peptide was a gift ofDr. F. Sinigaglia (Basel, Switzerland)
(21). The sequences of the peptides are given in Table I .
T Cell Clones.
￿
The T cell clones used in this study are summarized in Table 1. Some of
them have been described previously with regard to their antigen specificity and HLA class
II restriction (19, 20, 22-24).
CytotoxicityAssay.
￿
After overnight pulsing with antigen (5 Wg/ml), target cells were pelleted,
resuspended, and labeled with 100 FACT "Cr sodium chromate (Amersham International,
Amersham, UK) during 1 h at 37°C. After three washes, target cells were added to 96-well
round-bottomed plates (Costar 3799) in 100 pl ofmedium at 104 cells/wellin triplicate wells.
Effector cells were then added in 100 Al at the indicated E/T cell ratios. The plates were in-
cubated for 4 h and then centrifuged, afterwhich cell-free supernatants were collected from
each well, and "Cr release was counted in a gamma counter. The percent specific lysis was
calculated using the following formula: percent specific lysis = [(experimental release - spon-
taneous release)/(maximal release - spontaneous release)] x 100%. All cultures were set
up in Iscove's modified Dulbeccds Medium (Gibco Laboratories, Grand Island, NY) sup-
plemented with penicillin (100 Rg/ml), streptomycin (100 Ag/ml) (both Gibco Laboratories,
Grand Island, NY) and 10% pooled human AB serum.
Results
65-kD hsp or CS Peptide-dependent Lysis ofEBVBLCL Targets by CD4+ Cytotoxic T Cell
Clones. Peptide pulsed or nonpulsed HLA class II matched EBVBLCL cells were
used as target cells for freshly cultured CD4+ HLA class II-restricted T cell clones
that recognized specific peptides of the mycobacterial 65-kD hsp (see Table I). As
shown in Fig. 1, all clones strongly lysed target cells pulsed with the specific peptide
but not targets pulsed with irrelevant or no peptide. A control P. falciparum CS pep-
tide-specific CD4+ T cell clone, MGD5, was included that gave similar results.
Thus, T cell clones that recognize different peptides in combination with DR or
DO restriction elements and that are derived from different individuals, are cyto-
toxic for peptide-pulsed target cells.
Clones NlC8 and W2G2 were able to lyse EBVBLCL that had been pulsed with
the purified, whole recombinant 65-kD hsp. Clone RIF9 showed minimal lysis and
the other clones no lysis at all of recombinant 65-kD hsp pulsed EBVBLCL. Since
these latter clones are able to lyse macrophages under similar conditions (data not
shown), these results point to a relative presentation defect of these EBVBLCL to
some of the 65-kD hsp-specific T cell clones. This defect is apparently overcome
when peptide is used instead of the recombinant 65-kD molecule.OTTENHOFF AND MUTIS
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FIGURE 1.
￿
65-kD hsp or CS peptide-specific lysis of EBVBLCL targets by CD4' cytotoxic T
cell clones. CD4' effector T cell clones were added to target cells at the indicated E/T ratios.
Target cells were HLA classII matched or autologous EBV BLCL (104 cells/well) that had been
pulsed with antigen during 18 h before the 4-h "Cr-release assay. Antigens are indicated by the
following symbols: (") 416- 439 peptide of65-kD hsp, (O) 183-204 peptide of 65-kDhsp, (/)
3-28 peptide of 65-kD hsp, (*)412-425peptide of65-kDhsp, (p) r65kDhsp, (') 378-398 pep-
tide of CS, (A) no antigen.
One representative experiment (Table II) shows that the level of target cell lysis
is dependent on the peptide concentration during the pulsing phase. This further
underlines the antigen dependency and specificity of target cell lysis by CD4'
clones.
CD4+ 65-kD lup-specific CTL Lyse Themselves and Other CD4' CTL in the Presence of
Specific Peptide. Human T cell clones, incontrast to mouse T cells, strongly express
MHC class IIantigens. Syntheticpeptides can bind directly to MHC class II. Since
CTL usually are resistant to lysisby self- orother CTL or subcellular CTL compo-
nents, we investigated ifpeptide pulsed CTL would be susceptible to CTL-mediated
lysis. The results in Table III, A and B show that all65-kD hsp-specific CTL clones
lyse themselves as well as other autologous T cell clones that had been pulsed with
relevantpeptide. Both TCR-a/oand TCRy/Scells (datanot shown) are susceptible
tolysis. In contrast, an HLA mismatched clone(SCL 5.12, Table IIIA) is not lysed.
Although EBVBLCL can present (probably processed) native recombinant 65-
kD hsp to some T cell clones (W2G2, NIC8; Table IIIB), T cell clones are unable
to do so (Table IIIB).
So far, all tested 65-kD hsp peptide-specific CD4+ T cell clones are able to lyse
CD4' CTL in the presence ofappropriate peptide. Thus, ourresults show that pep-
tide-specific CD4+ CTL are able to lyse themselves as well as other CD4+ CTL
in the presence of specific peptide.OTTENHOFF AND MUTIS
￿
2015
TABLE II
Peptide Concentration Dependency of Target Cell Lysis
Target cell
EBV-BLCL
Target cells were incubated with the indicated peptide concentrations for 18 h
before labeling with 51Cr. Assays were set up in triplicate with 104 target cells
per well. Effector cells were added to wells at the indicated E/T cell ratios. 5'Cr
release in culture supernatants was determined after 4 h. Results are expressed
as percent specific lysis.
CD4+ 65-kD hsp Peptide-specific CTL Lyse HLA Class II Compatible CD8+ CTL Clones
in thePresence ofSpecific Peptide. Since most studies addressing the resistance ofCTL
against self-mediated killing have focused on the "classical" CD8+ CTL, we tested
four randomly selected HLA class II compatible CD8+ CTL clones, specific for
HLA class I/minortransplantation antigens (6, 25, 26). CTL C754.5w4 could only
be lysed by effector CTL R2F10 but not RIF9, as expected on the basis ofits HLA
DR phenotype (Table IV). The other three CD8+ CTL clones could be lysed by
both CD4+ CTL clones, provided that they had been pulsed with the proper 65-
kD peptide. The levels oflysis were much lower that those seen with EBVBLCL
targets, suggesting a partial butnot total protectionfromCTL-mediated lysis. Thus,
peptide-pulsed human CD8+ cytolytic CTL clones can be lysed by CD4+ CTL
clones, and therefore are not absolutely resistant against CTL-mediated Lsis.
CD4+ CTL-mediatedLysis Does Not Induce Nonspecific BystanderLysis.
￿
CD4+ T cell
clones have been reported to acquire nonspecific lytic activity upon long-term cul-
tureinIL-2. Althoughwe foundno evidencefor nonspecificlysis, we tested whether
the presence ofahigh dose ofrIL-2 inthe assaycould trigger such nonspecific lysis.
Lysis remained completely specific in the presence of excess rIL-2 (100 U/ml) or
after overnight preincubation oftarget cellswith an excess rIFN-y (250 U/ml) (data
not shown).
In Table V, subsequent experiments are shown in which unlabeled (cold) an-
tigen-pulsed targets were mixed with "Cr-labeled (hot) unpulsed targets in order
toexcludenonspecificbystanderlysis. Thethree experiments showthatCTL strongly
lyse hot, peptide-pulsed EBVBLCL. When peptide pulsed targets were added as
cold targetsto nonpulsed hot targets, the lysisofthe former didnotinduce significant
lysis of the latter, bystander targets. Three cold targets were tested: EBVBLCL,
K562 (a human NK target), andaCTLclone. Otherexperiments showed thatkilling
was an active, temperature- and contact-dependent process, including Cat+ influx
in CTL immediately upon activation by target cells (not shown). Thus, the effector
phase oflysis by CD4+ CTL is entirely specific and does not induce bystander lysis.
Cold Target Competition Experiments.
￿
Tofurtherconfirm thespecificity oflysis, cold
target competition experiments were carried out. Fig. 2 gives one representative ex-
Pulsed with
65-kD hsp peptide E/T : 50:1
Effector: RIF9
13:1 3:1 1:1
- 0 0 0 0
3-12 0.005 pg/ml 9 4 3 0
3-12 0.05 tug/ml 21 11 3 0
3-12 0.5 Fug/ml 39 33 19 16
3-12 5.0 Fug/ml 73 56 23 6
418-427 5.0 Fug/ml 0 0 1 1201 6
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TABLE III
Antigen-specific Lysis of CD4+ T Cells by CD4+ CTL
Reactive with 65-kD hsp of Mycobacteria
Target cells were incubated with 5 Wg/ml of the indicated antigens for 18 h before labeling
with 5'Cr (see footnote to Table II). The results are expressed as percent specific release.
" HLA mismatched clone.
A. Target cell
Pulsed with
65-kD hsp
peptide E/T: 100:1
RIF9
25:1 6:1
Effector cells
R2F10
100:1 25:1 6:1
RP171-2
100:1 25:1 6:1
EBV-BLCL 3-28 89 78 35 0 0 0 15 8 3
416-439 0 0 3 87 98 85 61 63 52
- 0 0 0 1 0 0 10 7 2
RIF9 3-28 82 50 42 0 0 0 ND ND ND
416-439 0 0 0 90 78 55 58 77 64
- 0 0 0 0 0 0 0 0 0
RUM 3-28 68 60 50 4 0 2 0 0 2
416-439 5 11 0 43 60 49 58 48 25
- 0 0 0 0 0 0 0 0 0
RP171-2 3-28 84 88 49 0 0 0 0 0 2
416-439 4 0 0 76 72 27 44 22 13
- 4 2 0 0 0 0 5 3 1
SCL5 .12" 3-28 3 4 1 0 0 0 0 0 1
416-439 0 0 0 0 0 0 0 0 0
- 3 2 0 0 0 0 0 2 0
Effector cells
W2G2 NIC8 N3A9
B. E/T: 100:1 25:1 6:1 100:1 25:1 6:1 100:1 25:1 6:1
EBV-BLCL r65 kD hsp 42 30 28 43 45 24 16 7 2
412-425 82 62 68 67 72 36 49 35 4
- 0 0 1 0 5 4 5 0 0
W2G2 r65 kD hsp ND ND ND ND ND ND ND ND ND
412-425 60 80 53 72 72 21 31 24 3
- 0 7 0 6 0 0 0 0 0
NIC8 r65 kD hsp 0 0 0 5 5 0 0 0 0
412-425 27 36 24 32 22 13 21 21 0
- 0 2 3 1 0 0 3 0 0
N3A9 r65 kD hsp 0 0 0 0 0 0 0 0 0
412-425 50 35 59 35 42 35 21 32 36
- 0 6 6 0 0 0 4 7 5
Effector: R3F10
E/T: 100:1 25 :1 6:1
EBV-BLCL 3-28 3 7 0
183-204 65 34 15
- 0 0 0
R3F10 3-28 0 0 0
183-204 51 37 0
- 0 0 0
RP151-1 3-28 0 0 0
183-204 39 35 0
- 0 0 0OTTENHOFF AND MUTIS
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TABLE IV
Lysis of CD8+ CTL Clones by CD4+ CTL Clones
Target cells were pulsed overnight with 5 Rg/ml of the indicated peptides. Assays were set up
in triplicate with 104 target cells per well. Effector cells were added to wells at the indicated
E/T cell ratios. 51Cr release in culture supernatants was determined after 4 h. Results are ex-
pressed as percent specific lysis .
ample. Lysis of peptide-pulsed EBVBLCL could be competed away in a dose-
dependent fashion by cold EBVBLCL that had been pulsed with the same peptide
(Fig. 2 A) but not by the nonpulsed cold target (Fig. 2 B). Peptide-pulsed but not
unpulsed EBVBLCL were very efficient in competing away lysis ofpeptide pulsed
CTL targets: (Fig. 2, C andD). When peptide-pulsed or nonpulsed CTLwere used
as cold competitorsfor peptide-pulsed EBVBLCL, a veryhigh spontaneous release
was observed because, as expected, these cold CTL efficiently lysed peptide pulsed
EBVBLCL (data not shown).
Similar datawere obtained for another CTL clone. Thus, although CD4+ CTL
efficientlylysepeptide-pulsedCTLtargets, they bind moreefficiently toEBVBLCL
targets. This may also explain the often lower levels oflysis that are observed with
CTL as compared with EBVBLCL targets (see Table III, A and B).
Effect of Target CellorEfector Cell Prepulsing with Peptide.
￿
We next tried to replace
theprepulsing oftarget cells with peptideby adding freepeptideintothe assay. Even
very high peptide concentration (up to 100 Ag/ml) gave suboptimal lysis as com-
pared with lysis of targets that had been pulsed overnight (5 Ag/ml) (not shown).
This wasunexpected since in other studies, the addition offree (tetanus toxoid)pep-
tide to EBVBLCL led to an almost immediate Ca" influx in an antigen-specific
CD4+ T cell clone (27). Besides considering other explanations (the slow HLA-
peptide complex formation [28]; the higher complexity oftarget cell lysis as com-
pared with merely TCR/CD3 signaling; the induction ofpeptide-dependent self-
mediated CTL killing in the presence ofthe free peptide), we tested whether the
direct binding offree peptide to the TCR possibly interfered with (orled to) target
Target cell
HLA-DR
type
Pulsed with
65-kD hsp
peptide E/T: 100:1
CD4+ effector cells
RIF9 R2F10
25:1 6:1 100:1 25:1 6:1
EBV-BLCL 2,3 3-28 88 64 24 0 6 6
416-439 2 0 3 86 64 53
- 4 2 0 3 5 3
CD8+ CTL 3-28 1 2 2 0 1 1
Wam C754.SW4 1,2 416-439 0 0 1 24 20 13
- 0 0 0 0 0 2
CD8+ CTL 3-28 23 33 19 0 0 7
Hel1E6 2,3 416-439 0 3 3 29 23 20
- 1 5 5 0 5 8
CD8+ CTL 3-28 11 13 10 0 2 6
Hel5H4 2,3 416-439 1 0 3 28 36 15
- 2 2 4 1 0 4
CD8+ CTL 3-28 36 15 12 0 5 6
He11E4 2,3 416-439 0 2 6 28 25 38
- - - 0 0 0 0 0 02018
￿
CD4' CYTOTOXIC T CELL CLONES
TABLE V
CD4+ CTL Lyse Target Cells in the Absence of Bystander Lysis
Target cells were preincubated with or without peptide and used as S 'Cr labeled (hot) or unlabeled (cold)
targets. Experiments were set up in triplicate wells to which 104 hot and if indicated 104 cold targets were
added. Effector cells were then added at the indicated E/T (hot) ratios. SICr release in the supernatants was
determined after 4 h. Results are expressed as percent specific lysis.
cell killing. Effector cells were preincubated overnight with peptide and then added
to peptide pulsed or nonpulsed target cells (Table VI). The preincubation ofCTL
did not result in lysis ofunpulsed EBVBLCL, suggesting that the formation of a
functional TCRpeptide-MHC complex did not take place under these conditions.
Lysis ofpeptide-pulsed target cells was not abrogated, showing that CTL peptide
pretreatment did notblock TCRmediated recognition ofMHC boundpeptide. On
the other hand, quantitative differences were observed: at higher E/T ratios, less
efficient killing by pretreated CTL was seen, probably as a result of "cold effector"
competition with peptide pulsed targets. At lower E/T ratios, killing was enhanced
rather than inhibited. This could be accounted for by the preactivation of CTLs
bypeptide, and based onthe above results, is not a consequence ofenhanced TCR
antigen-MHC complex formation by TCRbound free peptide.
Discussion
Until recently, cell-mediated immunity to intracellular organisms was thought
to depend exclusively on CD4+ antigen-specific helper T lymphocytes: upon acti-
Exp.
Hot target pulsed
with 65-kd hsp
peptide
Cold target +
pulsed with 65-kD R2F10
hsp peptide E/T: 100:1 25:1 6:1
Effector cells
RP171-2
100:1 25:1 6:1 100:1
RIF9
25:1 6:1
1 BLCL + 3-28 - 0 0 0 15 8 3 89 78 35
BLCL + 416-439 - 87 98 85 61 63 52 0 0 3
BLCL unpulsed - 1 0 0 10 7 2 0 0 0
BLCL unpulsed BLCL + 3-28 ND ND ND ND ND ND 7 2 0
BLCL unpulsed BLCL + 416-439 16 5 3 18 11 2 ND ND ND
R2F10
E/T: 100:1 25:1 6:1
2 BLCL + 416-439 - 97 82 48
BLCL unpulsed - 0 0 0
K562 BLCL + 416-439 0 5 0
K562 BLCL unpulsed 5 1 0
RIF9
E/T: 50:1 15 :1 5:1
3 BLCL + 3-12 - 80 39 8
BLCL unpulsed - 0 4 2
RIF9 + 3-12 - 56 37 16
RIF9 unpulsed 0 6 0
BLCL unpulsed BLCL + 3-12 1 3 1
BLCL unpulsed R1F9 + 3-12 0 4 ND
RIF9 unpulsed BLCL + 3-12 0 0 0
RIF9 unpulsed RIF9 + 3-12 0 0 0100
￿
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FIGURE 2.
￿
Inhibition ofpeptide-specific hot target
cell lysis by peptide-pulsed or unpulsed cold target
cells. Target cells were pulsed with 65-kD hsppep-
tide 3-12 (5 ug/ml) for 18 h. 5 x 103 51Cr-labeled
target cells were mixed with unlabeled cold target
cells at different cold/hot target ratios: (0) 50:1, (")
15:1, (+) 5:1, (m)no cold target added. Tcell clone
RIF9 was used as effector cell in the experiment
shown and added into wells at the indicated
effector/hot target ratios. "Cr release in the culture
supernatants wasassessed after 4 h incubation. (A)
Hot target:EBVBLCL pulsed with peptide 3-12,
Cold target:EBVBLCL pulsed with peptide 3-12; (B)
Hot target:EBVBLCL pulsed with peptide 3-12,
Cold target:EBVBLCL not pulsed, (C Hot tar-
get:R1F9 pulsed with peptide 3-12, Cold target:EBV
BLCL pulsed with peptide 3-12; (D) Hottarget:R1F9 .
pulsed with peptide 3-12, Cold target:EBVBLCL not
pulsed.
vation by antigen/MHC class II, these cells would releaselymphokines such as IFN-1'
and thereby "help" or activate antimicrobial effector functions in the macrophage.
This relatively simple scenario has recently been challenged, first by observations
in anumber of experimental infections in mice, including infections with Mycobac-
teria sp., where CD4+ and CD8+ CTL could be isolated that were able to lyse mac-
rophages (reviewed in reference 2). Those studies led us and others to reexamine
the type of effector cells that were generated in the human immune response to
mycobacteria. In summary, it was found that mycobacteria highly efficiently induced
TABLE VI
Effect of Peptide Preincubation of Effector Cells on Antigen-specific Lysis of Target Cells
Target cells or effector cells were preincubated with 5 Ag/nil of the indicated antigens for 18 handthen washed
three times. Assays were set up in triplicate (104 cells/well). The results are expressed as percent specific lysis.
Target cell
Pulsed with
65-kD hsp peptide
Preincubated with:
E/T: 100:1
No peptide
25:1 6:1
Effector: RIF9
65-kD hsp
2:1 100:1 25 :1
peptide
6:1
3-28
2:1
EBV-BLCL 3-28 100 96 43 14 54 49 64 , 44
EBV-BLCL 416-439 0 0 2 1 10 10 7 5
EBV-BLCL - 9 8 0 0 6 0 2 0
Effector: R2F10
Preincubated with: No peptide 65-kD hsp peptide 416-439
E/T: 100:1 25:1 6:1 2:1 100:1 25:1 6:1 2:1
EBV-BLCL 3-28 0 3 0 1 9 4 0 0
EBV-BLCL 416-439 79 20 22 17 35 69 63 23
EBV-BLCL - 0 4 7 2 9 0 0 62020
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antigen-specific, HLA-restricted CD4+ and CD8+ CTLs, as well as antigen non-
specific unrestricted killer cells(3-5). Each oftheseeffector cellslysedmacrophages.
Recent studies in which rIL-2, rIFN-,y, or purified protein derivative (PPD) was
injected into lepromatous leprosypatients' skin (29-31), and other studies in which
in situ hybridization techniques were used (32) have also indirectly supported an
important role for cytotoxic T cells in leprosy. Based on these new findings, the clas-
sical concept ofcell-mediated immunity needs to be reconsidered, since it has be-
come apparent that not only "macrophage-help" but also "macrophage-lysis" may
be aneffector mechanismin thecellular immuneresponse tomycobacteria. Wethere-
fore wanted to gain further insight intothe antigen specificity and function ofCTL
directed towards mycobacterial pathogens. We have demonstrated earlier that the
mycobacterial 65-kD hsp is an important target antigen for CD4+ CTL (3, 5).
These CTL were readily detectable after a single antigen exposure in vitro.
Wehave nowanalyzed the CTL responseto this immunodominant antigen, using
a panel ofCTL clones. These CD4+ CD8' CTL recognize M. leprae 65-kD hsp pep-
tides presented by HLA class II molecules and display strong cytotoxic activity to-
wards specific peptide-pulsed EBVBLCLtarget cells. Furtherexperiments have ex-
tended these results to macrophages as target cells (data not shown). At least four
different 65-kD hsp epitopes are able to trigger CTLs. Lysis of target cells was en-
tirely specific and did not result in bystander lysis of EBVBLCL, tumor cells or
other CTL clones, although the CD4+ CTL release nonspecific serine esterases
upon activation (unpublished observations). As far as we are aware, this is one of
the first examples ofpeptide-specific CTL in a human infectious disease caused by
intracellular parasites. Two other recombinant M. leprae antigens carry epitopes for
CD4+ cytotoxic T cell clones, namely the recombinant 18-kD antigen and a newly
defined molecule, 13B3 (33). These findings are in agreement with ours, and show
that also non-65-kD antigens can be recognized by CD4' CTL. We are presently
also investigating other M. leprae antigens for their ability to serve as CTL target
antigens. It will also be important to correlate our findings to the capacity ofthese
CTL to produce lymphokines, since in mice (34) and maybe also in man (36) CD4+
Thl but not Th2 cells possess lytic potential.
An unexpected and novel finding in the present study was that CD4+ CTLs are
able to lyse CD4+ or CD8* CTL clones that bear the proper HLA class II/peptide
ligand. CTLare thought to be resistant toself-mediated lysis. Although during target
cellkilling CTL can avoid self-mediated killing by theunidirectional delivery oflytic
granule compounds specifically to the target cell (36), also an active protection of
CTL against lytic components has been proposed (e.g., 8-10), since CTL are un-
usually or sometimes even completely resistant to lysis by CTL or CTL products.
For instance, cloned CTL are highly resistant to lysis by (other or self) CTL in a
lectin-dependent cytotoxicity assay (14). In another study, a CTL clone efficiently
lysed noncytotoxic helper T cells but only marginally lysed CTL targets, although
the latter were properly recognized as evident from cold target competition experi-
ments (12). A good correlation was found between cytotoxic capacity and resistance
ofCTL clones (13, 18). In contrast to their target cells, CTL themselves are highly
resistant to lysis by purified CTL-derived cytotoxic granules (11, 14, 15), by highly
purified perforin (17, 37). The same was found for primary, uncloned CTL (11).
It should be pointedout, however, that these studies were performed with murineOTTENHOFF AND MUTIS
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CTL that were almost always ofthe CD8' phenotype. These CTL may well differ
from our human CD4' CTL. Our 65-kD hsp-specificCTL only lysed CTL targets
that had been pulsed with free peptide but not with native hsp 65, suggesting that
T cells do not endocytose and/or process native antigen. An exception may be an-
tigens that specifically bind to recycling T cell membrane molecules. For instance,
the gp120 HIV proteinbindsto CD4, is endocytosed, processed, andthen presented
to gp120-specific CD4+ CTL that subsequently lyse CD4' class II' target cells(38).
OurCTL do not give bystander lysis. This findingcontrastswith the recent sug-
gestion that activated CTL have detectable affinity for selfMHC, as determined
bybystander lysis ofautologous or syngeneic target cells (39). Differences in target
and effectorcells mayexplain these discrepant results. Peptide preincubation ofeffector
cells did not lead to lysis ofunpulsed targets, showingthat iffree peptide can bind
tothe TCR atall, it isunable to induce theformation ofafunctional peptide-MHC-
TCR complex. Peptide preincubation of effector cells did not also abrogate lysis
ofpeptidepreincubated target cells, butled tomore efficientlysis at lowerE/T ratios,
probably as a result of CTL preactivation by self presentation.
What is the possible in vivo relevance ofCTL-mediated T cell killing? It is con-
ceivable that CTL that lyse M. leprae-infected macrophages, become exposed to the
intracellular breakdown products of the target cell, including polypeptides of the
highly abundant 65-kD hsp of the infecting organism. These peptides might then
bind toclassII on the CTL surface andrender themtargetsfor CTL-mediated lysis.
Mycobacterial granulomas in particular may contain abundant cellular and bac-
terial debris including such peptides. Cytolytic T-T interactions may be involved
in downregulating local T cell responses and represent a novel immunoregulatory
pathway that wouldexclusivelybefound in man, since murine Tcells do notexpress
MHC class II. Human T cell clones can indeed present antigen (our unpublished
observations; 40), and cytotoxic T-T cell interactions may contribute to the deple-
tion of CD4+ T cells in HIV infections (38). Regulatory anticlonotypic cytotoxic
T-T cell interactions have also been described in experimental autoimmune en-
cephalomyelitis in mice (41).
Another immunoregulatory pathway in which mycobacterial antigen-reactive CTL
maybeinvolvedis thedownregulation ofspecificB cellresponses(42). Because antigen-
specific B cells express specific Igreceptors, they are much more efficient in the up-
take, and hence presentation ofprocessed antigen to T cells when compared with
nonspecificB cells. Itis conceivable that the CTL-mediated selectivekillingofspecific
B cells may, at least inpart, explain why tuberculoidleprosy patients are good CTL
responders to M. leprae and have low specific antibody titers, whereas the opposite
is seen in lepromatous patients.
Inconclusion, wehave shown that mycobacterial peptide-specific HLA classII-re-
stricted CD4' T cell clones display strong specific cytolytic activity towards both
APCs, and, unexpectedly, CD4' and CD8' CTL clones, including themselves.
Since, in contrast to murine T cells human T cells express class II, CTL-mediated
T cell killing may represent a novel immunoregulatory pathway in man.
Summary
Mycobacterial antigens not only stimulate Th cells that produce macrophage-
activating factors, but also CD4' and CD8' CTL that lyse human macrophages.2022
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The mycobacterial recombinant 65-kD hsp was previously found to be an important
target antigen for polyclonal CD4' CTL. Because of the major role of 65-kD hsp
in the immune response to mycobacterial as well as autoantigens, we have studied
CTL activity to this protein at the clonal level. HLA-DR or HLA-DQ, restricted,
CD4+CD8- T cell clones that recognize different peptides of the M. leprae 65-kD
hsp strongly lysed EBVBLCL pulsed with specific but not irrelevant peptide. No
bystander lysis of B cells, T cells, or tumor cells was seen. Target cell lysis could
not be triggered by PMA + Ca" ionophore alone and depended on active metab-
olism. Interestingly, these CD4+ CTL also strongly lysed themselves and other
HLA-class II compatible CD4+ (TCRa/(3 or -y/b) or CD8 + CTL clones in the
presence of peptide, suggesting that CTL are not actively protected from CTL-
mediated lysis. Cold target competition experiments suggested that EBVBLCL targets
were more efficiently recognized than CD4+ CTL targets. These results demon-
strate that hsp65 peptide-specific HLA class II-restricted CD4+ T cell clones dis-
play strong peptide-dependent cytolytic activity towards both APCs, and, unexpectedly,
CD4+ and CD8+ CTL clones, including themselves. Since, in contrast to murine
T cells human T cells express class II, CTL-mediated T cell killing may represent
a novel immunoregulatory pathway in man.
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Goulmy for providing CD8+ CTL clones, Francesco Sinigaglia for providing T cell clone
MGD5, Jan van Embden for providing the hsp 65, Dienne Bontrop-Elferink and Yolanthe
Cornelisse for expert technical assistance, and Rene de Vries, Frits Koning, andJim Kurnick
for reviewing and MariRte Mulder for preparing the manuscript.
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